- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 223/12 - Nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 223/12
Total number of patents in this class: 61
10-year publication summary
|
7
|
6
|
3
|
3
|
4
|
2
|
2
|
5
|
4
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2715 |
5 |
| Oryzon Genomics S.A. | 103 |
5 |
| BioMarin Pharmaceutical Inc. | 400 |
3 |
| Bristol-myers Squibb Company | 4729 |
2 |
| Syngenta Participations AG | 1527 |
2 |
| Astellas Pharma Inc. | 1043 |
2 |
| Cambridge Enterprise Limited | 1243 |
2 |
| Chubu University Educational Foundation | 100 |
2 |
| Draths Corporation | 4 |
2 |
| Seikagaku Corporation | 168 |
2 |
| Taisho Pharmaceutical Co., Ltd. | 851 |
2 |
| Universita degli Studi di BARI "aldo Moro" | 51 |
2 |
| Lunella Biotech, Inc. | 102 |
2 |
| Beactica Therapeutics AB | 2 |
2 |
| The Regents of the University of California | 20720 |
1 |
| Merck Sharp & Dohme Corp. | 2183 |
1 |
| Boehringer Ingelheim International GmbH | 4493 |
1 |
| Janssen Pharmaceutica N.V. | 3171 |
1 |
| Bausch & Lomb Incorporated | 1064 |
1 |
| Cephalon, Inc. | 104 |
1 |
| Other owners | 20 |